                         SEQUENCE LISTING

<110>  Yissum Research Development Company of the Hebrew 
       University of Jerusalem Ltd.
 
<120>  BACKBONE CYCLIZED INHIBITORY PEPTIDES OF MYELOID DIFFERENTIATION 
       FACTOR 88 (MYD88)

<130>  YISSUM-0131-PCT

<150>  US 62/346,580
<151>  2016-06-07

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  1

Arg Asp Val Leu Pro Gly Thr 
1               5           


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  2

Arg Asp Val Leu 
1               


<210>  3
<211>  146
<212>  PRT
<213>  Homo sapiens

<400>  3

Asp Asp Pro Leu Gly His Met Pro Glu Arg Phe Asp Ala Phe Ile Cys 
1               5                   10                  15      


Tyr Cys Pro Ser Asp Ile Gln Phe Val Gln Glu Met Ile Arg Gln Leu 
            20                  25                  30          


Glu Gln Thr Asn Tyr Arg Leu Lys Leu Cys Val Ser Asp Arg Asp Val 
        35                  40                  45              


Leu Pro Gly Thr Cys Val Trp Ser Ile Ala Ser Glu Leu Ile Glu Lys 
    50                  55                  60                  


Arg Cys Arg Arg Met Val Val Val Val Ser Asp Asp Tyr Leu Gln Ser 
65                  70                  75                  80  


Lys Glu Cys Asp Phe Gln Thr Lys Phe Ala Leu Ser Leu Ser Pro Gly 
                85                  90                  95      


Ala His Gln Lys Arg Leu Ile Pro Ile Lys Tyr Lys Ala Met Lys Lys 
            100                 105                 110         


Glu Phe Pro Ser Ile Leu Arg Phe Ile Thr Val Cys Asp Tyr Thr Asn 
        115                 120                 125             


Pro Cys Thr Lys Ser Trp Phe Trp Thr Arg Leu Ala Lys Ala Leu Ser 
    130                 135                 140                 


Leu Pro 
145     


<210>  4
<211>  21
<212>  PRT
<213>  Mus musculus

<400>  4

Met Glu Val Gly Trp Tyr Arg Ser Pro Phe Ser Arg Val Val His Leu 
1               5                   10                  15      


Tyr Arg Asn Gly Lys 
            20      


<210>  5
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  5

Pro Thr Asp Leu Val Arg Gly 
1               5           


